Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Lundon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Pediatric Urology|May 4, 2012
Methylphenidate-induced erections in a prepubertal childB D Kelly, D J Lundon, D McGuinness, et al.
BJUI Compass|April 27, 2022
Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsyG Wei, B D Kelly, B Timm, et al.
Medicina Intensiva|September 11, 2020
Early mortality risk stratification after SARS-CoV-2 infectionD J Lundon, B D Kelly, S Nair, et al.
Medicina Intensiva|October 31, 2021
Early mortality risk stratification after SARS-CoV-2 infectionD J Lundon, B D Kelly, S Nair, et al.
Irish Journal of Medical Science|January 6, 2017
Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014P J Stapleton, D J Lundon, R McWade, et al.
Irish Journal of Medical Science|January 20, 2017
Dynamic sentinel node biopsy for penile cancer: an initial experience in an Irish HospitalP E Lonergan, A Nic An Riogh, F O'Kelly, et al.
Irish Journal of Medical Science|April 7, 2015
Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral populationR W Foley, D J Lundon, K Murphy, et al.
World Journal of Urology|August 6, 2014
Prostate cancer risk assessment tools in an unscreened populationD J Lundon, B D Kelly, R Foley, et al.
BMC Cancer|March 3, 2017
The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validationD J Lundon, A Boland, M Prencipe, et al.
Cell Communication and Signaling : CCS|July 21, 2021
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic diseaseM Archer, N Dogra, Z Dovey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Pediatric Urology|May 4, 2012
Methylphenidate-induced erections in a prepubertal childB D Kelly, D J Lundon, D McGuinness, et al.
BJUI Compass|April 27, 2022
Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsyG Wei, B D Kelly, B Timm, et al.
Medicina Intensiva|September 11, 2020
Early mortality risk stratification after SARS-CoV-2 infectionD J Lundon, B D Kelly, S Nair, et al.
Medicina Intensiva|October 31, 2021
Early mortality risk stratification after SARS-CoV-2 infectionD J Lundon, B D Kelly, S Nair, et al.
Irish Journal of Medical Science|January 6, 2017
Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014P J Stapleton, D J Lundon, R McWade, et al.
Irish Journal of Medical Science|January 20, 2017
Dynamic sentinel node biopsy for penile cancer: an initial experience in an Irish HospitalP E Lonergan, A Nic An Riogh, F O'Kelly, et al.
Irish Journal of Medical Science|April 7, 2015
Predicting prostate cancer: analysing the clinical efficacy of prostate cancer risk calculators in a referral populationR W Foley, D J Lundon, K Murphy, et al.
World Journal of Urology|August 6, 2014
Prostate cancer risk assessment tools in an unscreened populationD J Lundon, B D Kelly, R Foley, et al.
BMC Cancer|March 3, 2017
The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validationD J Lundon, A Boland, M Prencipe, et al.
Cell Communication and Signaling : CCS|July 21, 2021
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic diseaseM Archer, N Dogra, Z Dovey, et al.
Pageof 1